Advancing Cancer Care Across Asia: NCCH and NCCS Expand Collaboration in Clinical Research, Professional Exchange, and Education

July 29, 2026
In Japanese

On July 10, National Cancer Center Hospital (NCCH) and National Cancer Centre Singapore (NCCS) signed a Memorandum of Understanding (MoU), marking another important step in strengthening collaboration between the two institutions.

As the lead institution of the ATLAS (Asian Clinical Trials Network for Cancers) Project, NCCH is committed to advancing multinational clinical trials and accelerating access to innovative cancer treatments across Asia.

This MoU will further advance collaboration between NCCH and NCCS, particularly in the areas of clinical research, human exchanges, and education, with the aim of improving cancer care across Asia.

To commemorate this important milestone, Dr. Yasuyuki Seto, Director of NCCH, and Prof. Lim Soon Thye, Chief Executive Officer of NCCS, exchanged a handshake following the signing ceremony, symbolizing the shared commitment of both institutions to advancing cancer research and patient care across Asia.

We look forward to continuing our collaboration with NCCS and our partners across Asia through the ATLAS Project to accelerate innovation and improve outcomes for patients.

Left: Representatives of NCCH and NCCS during discussions
Right: Dr. Yasuyuki Seto (NCCH, left) and Prof. Lim Soon Thye (NCCS, right) exchange a handshake following the signing ceremony